AJP - Endocrinology and Metabolism, Vol 265, Issue 5 E814-E820, Copyright © 1993 by American Physiological Society

ARTICLES

Model for measuring absolute rates of hepatic de novo lipogenesis and reesterification of free fatty acids

M. K. Hellerstein, R. A. Neese and J. M. Schwarz
Department of Nutritional Sciences, University of California, Berkeley 94720.

We have previously presented a precursor-product stable isotopic technique for measuring in vivo the fraction of very low-density lipoprotein-fatty acids (VLDL-FA) derived from de novo lipogenesis (fractional DNL). Here, we propose a technique for converting fractional DNL into absolute rates of DNL and describe its explicit underlying assumptions. The technique combines the fractional DNL method with a modification of the method of S. Klein, V. R. Young, G. L. A. Blackburn, B. R. Bistrain, and R. R. Wolfe (J. Clin. Invest. 78: 928-933, 1986), for estimating hepatic reesterification of free fatty acids (FFA). Infusions of [1,2,3,4-13C]palmitate and [1-13C]acetate are performed concurrently with indirect calorimetry in human subjects. Fractional DNL (based on mass isotopomer distribution analysis of VLDL-FA), the rate of appearance of plasma FFA (Ra of FFA), and net fat oxidation in the whole body are measured. Equations from the hepatic reesterification model, modified to include the contribution from DNL, allow calculation of absolute DNL (= fractional DNL x [Ra of FFA - net whole body fat oxidation], when respiratory quotient < 1.0). Sample results from human subjects with different dietary energy intakes are presented, with calculations of absolute DNL, absolute reesterification, and absolute fat oxidation rates. The assumptions of this technique (in particular, that all fat oxidized is derived at steady state from circulating FFA and that DNL and reesterification of FFA both occur exclusively in liver) are discussed.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. M. Turner, S. Roy, H. S. Sul, R. A. Neese, E. J. Murphy, W. Samandi, D. J. Roohk, and M. K. Hellerstein Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1101 - E1109. [Abstract] [Full Text] [PDF]

				S. M. Turner, E. J. Murphy, R. A. Neese, F. Antelo, T. Thomas, A. Agarwal, C. Go, and M. K. Hellerstein Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E790 - E803. [Abstract] [Full Text] [PDF]

				J. D. Morrisett, G. Abdel-Fattah, R. Hoogeveen, E. Mitchell, C. M. Ballantyne, H. J. Pownall, A. R. Opekun, J. S. Jaffe, S. Oppermann, and B. D. Kahan Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients J. Lipid Res., August 1, 2002; 43(8): 1170 - 1180. [Abstract] [Full Text] [PDF]

				M. D. Jensen, K. Ekberg, and B. R. Landau Lipid metabolism during fasting Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E789 - E793. [Abstract] [Full Text] [PDF]

				F. Diraison and M. Beylot Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E321 - E327. [Abstract] [Full Text] [PDF]